Results 111 to 120 of about 58,451 (152)

Immunometabolic Organ Crosstalk in Heart Failure with Preserved Ejection Fraction: The Role of Dietary Patterns in Obesity-Related Inflammation. [PDF]

Nutrients
Kalisz M, Litwiniuk A, Sławkowska N, Stępień D, Bik W.   +4 more
europepmc   +1 more source

Circulating nitric oxide pathway metabolites in heart failure with preserved ejection fraction: a sex-stratified cross-sectional analysis. [PDF]

Biol Sex Differ
Dinges SM, Schwedhelm E, Baldassarri F, Haller B, Gevaert AB, Böger R, Winzer EB, Edelmann F, Wisløff U, Adams V, Pieske B, Van Craenenbroeck EM, Halle M, Hofmann SM, Mueller-Stegner S.   +14 more
europepmc   +1 more source

Clinical Advances in Heart Failure with Preserved Ejection Fraction: A Systematic Review of Therapeutic and Mechanistic Evidence. [PDF]

Vasc Health Risk Manag
Parizad R, Hatwal J, Taban Sadeghi M, Brar A, Desai R, Batta A, Mohan B.   +6 more
europepmc   +1 more source

A simple nomogram to help guide the diagnosis of cardiac amyloidosis in patients with heart failure with preserved ejection fraction. [PDF]

Quant Imaging Med Surg
Yang Q, Li R, Yang H, Liu Y, Liu F, Yan J, Zeng R, Li C, Zeng H, Wang H.   +9 more
europepmc   +1 more source

Cardiac metabolic remodeling drives dicarbonyl stress-induced mitochondrial dysfunction in experimental heart failure with preserved ejection fraction. [PDF]

Am J Physiol Heart Circ Physiol
Aryal A, Mobasheran P, Bishop L, Chatterjee S, Jennings S, Xia H, Lazartigues E, Yang Q.   +7 more
europepmc   +1 more source

Association of left ventricular geometry with outcomes and treatment response in atrial fibrillation and heart failure with preserved ejection fraction. [PDF]

Front Med (Lausanne)
Ren L, Peng X, Li M, He L, Zhou N, Liu X, Zuo S, Dong J, Ma C, Guo X.   +9 more
europepmc   +1 more source

Empagliflozin in Heart Failure with a Preserved Ejection Fraction [PDF]

New England Journal of Medicine, 2021
Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction are uncertain.In this double-blind trial, we randomly assigned 5988 patients with class II-IV heart failure and ...
Nikolaus Marx, Nadia Giannetti, Faiez Zannad   +2 more
exaly   +8 more sources

Spironolactone for Heart Failure with Preserved Ejection Fraction [PDF]

New England Journal of Medicine, 2014
Mineralocorticoid-receptor antagonists improve the prognosis for patients with heart failure and a reduced left ventricular ejection fraction. We evaluated the effects of spironolactone in patients with heart failure and a preserved left ventricular ejection fraction.In this randomized, double-blind trial, we assigned 3445 patients with symptomatic ...
Bertram Pitt, Song Yang, Brian Claggett   +2 more
exaly   +11 more sources